Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2020-10-29T14:38:41Z
dc.date.available 2020-10-29T14:38:41Z
dc.date.issued 2019
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/107933
dc.description.abstract Lung transplantation is a lifesaving therapy for people living with severe, life-threatening lung disease. The high mortality rate among patients awaiting transplantation is mainly due to the low percentage of lungs that are deemed acceptable for implantation. Thus, the current shortage of lung donors may be significantly reduced by implementing different therapeutic strategies which facilitate both organ preservation and recovery. Here, we studied whether the anti-inflammatory effect of human umbilical cord-derived mesenchymal stem cells (HUCPVCs) increases lung availability by improving organ preservation. We developed a lung preservation rat model that mimics the different stages by which donor organs must undergo before implantation. The therapeutic schema was as follows: cardiac arrest, warm ischemia (2 h at room temperature), cold ischemia (1.5 h at 4°C, with Perfadex), and normothermic lung perfusion with ventilation (Steen solution, 1 h). After 1 h of warm ischemia, HUCPVCs (1 × 106 cells) or vehicle was infused via the pulmonary artery. Physiologic data (pressure-volume curves) were acquired right after the cardiac arrest and at the end of the perfusion. Interestingly, although lung edema did not change among groups, lung compliance dropped to 34% in the HUCPVC-treated group, while the vehicle group showed a stronger reduction (69%, p < 0 0001). Histologic assessment demonstrated less overall inflammation in the HUCPVC-treated lungs. In addition, MPO activity, a neutrophil marker, was reduced by 41% compared with vehicle (p < 0 01). MSC therapy significantly decreased tissue oxidative damage by controlling reactive oxygen species production. Accordingly, catalase and superoxide dismutase enzyme activities remained at baseline levels. In conclusion, these results demonstrate that the anti-inflammatory effect of MSCs protects donor lungs against ischemic injury and postulates MSC therapy as a novel tool for organ preservation. en
dc.language en es
dc.subject lungs es
dc.subject transplantation es
dc.subject ischemia es
dc.title Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia en
dc.type Articulo es
sedici.identifier.uri http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC6701419&blobtype=pdf es
sedici.identifier.uri https://www.hindawi.com/journals/sci/2019/8089215/ es
sedici.identifier.other pmid:31481974 es
sedici.identifier.other pmcid:PMC6701419 es
sedici.identifier.other http://dx.doi.org/10.1155/2019/8089215 es
sedici.identifier.issn 1687-9678 es
sedici.creator.person Pacienza, Natalia es
sedici.creator.person Santa Cruz, Diego es
sedici.creator.person Malvicini, Ricardo es
sedici.creator.person Robledo, Oscar Juan Alberto es
sedici.creator.person Lemus Larralde, Gastón es
sedici.creator.person Bertolotti, Alejandro es
sedici.creator.person Marcos, Martín Alejandro es
sedici.creator.person Yannarelli, Gustavo es
sedici.subject.materias Ciencias Médicas es
sedici.subject.materias Veterinaria es
sedici.description.fulltext true es
mods.originInfo.place Facultad de Ciencias Veterinarias es
sedici.subtype Articulo es
sedici.rights.license Creative Commons Attribution 4.0 International (CC BY 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Stem Cells International es
sedici.relation.journalVolumeAndIssue vol. 2019 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution 4.0 International (CC BY 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution 4.0 International (CC BY 4.0)